Medications
Doctors use medicines to treat
dementia in the following ways:
- To correct an underlying condition causing dementia, such as
thyroid replacement for
hypothyroidism, vitamins for lack of vitamin B12, or
antibiotics for infections
- To maintain mental functioning for as
long as possible when dementia cannot be reversed
- To prevent
worsening of
vascular dementia from future small strokes in people
with high blood pressure and high cholesterol
- To manage
depression, insomnia,
hallucinations, agitation, and aggression
Medication Choices
Doctors may prescribe the following medicines to help
maintain mental function:
-
Cholinesterase inhibitors such as donepezil (Aricept),
galantamine (Reminyl), and rivastigmine (Exelon). These were developed to treat
Alzheimer's disease, but they may be tried in other
dementias to improve or maintain mental function. Recent studies indicate that
this class of drugs holds promise for the treatment of people with vascular
dementia. Both donepezil and galantamine have been shown to improve mental
function with few side effects.10, 11 Rivastigmine was also beneficial for people with
dementia with Lewy bodies or
Parkinson's disease, but side effects such as nausea,
vomiting, and weight loss were common.12 At present,
medicines can only slow, not stop, the progress of dementia. It is not clear
how long these medicines will work. They may only stop the progress of dementia
for a short time.
-
Memantine (Namenda). This is a type of medicine that
can slow the late stages of Alzheimer's disease. It may also benefit those with
mild to moderate vascular dementia.13, 12 More studies are under way.
The doctor may prescribe medicines for high blood
pressure and high cholesterol, since these conditions are risk factors for
vascular dementia.25 These drugs cannot reverse
existing dementia, but they may prevent future strokes and heart disease that
can lead to further brain damage. For more information, see the topics
High Blood Pressure (Hypertension),
High Cholesterol, and
Transient Ischemic Attack (TIA).
Medicines that doctors may use to help control mood or behavior problems
include:
- Antidepressants to treat depression, which is
common in dementia. They must be used with caution, because they can cause
delirium in people with dementia. Antidepressants that
have the fewest side effects in people with dementia are the
selective serotonin reuptake inhibitors (SSRIs), such
as fluoxetine (Prozac, for example) and citalopram (Celexa).14
-
Medicines such as risperidone (Risperdal) or
olanzapine (Zyprexa), called antipsychotic drugs. Doctors may use these to
treat symptoms such as anxiety, agitation, aggression, sleep problems, firmly
held false beliefs (delusions), and hallucinations. Antipsychotic drugs are not
approved by the FDA for the treatment of dementia. Studies of people with
psychosis due to dementia who were treated with these medicines found an
increased risk of death. Discuss this risk with your doctor before taking these
medicines.
What To Think About
Rivastigmine (Exelon) can now be
given through a skin patch. Skin patches release medicine into the blood at a
steady level and may reduce side effects. And it’s easier for caregivers to
make sure a person is taking the medicine properly when the person uses a skin
patch.
The medicines risperidone (Risperdal) and olanzapine
(Zyprexa) have been found to reduce behavior problems and
psychosis in people with dementia.12 However, these and similar drugs have some known
risks:
- The U.S. Food and Drug Administration (FDA)
issued a public health advisory stating that people with dementia who use
antipsychotics may die sooner than those who don't use these drugs. Examples of
these antipsychotics include haloperidol (Haldol), olanzapine (Zyprexa),
quetiapine (Seroquel), and risperidone (Risperdal).
- The makers of
Risperdal have issued a warning that older adults taking this medicine may have
a slightly higher risk of stroke.
Several new medicines have been studied, including
oxiracetam and pentoxifylline. These medicines are experimental and have not
yet been rigorously studied for dementias other than Alzheimer's.
Studies have found daily use of SSRIs may increase the risk of bone
fracture in adults over age 50. Talk to your doctor about this risk before
taking an SSRI.26
FDA advisory about antidepressants. The FDA has issued an advisory to
patients, families, and health professionals to closely monitor for signs of
suicidal behavior in adults and children taking antidepressants. This is
especially important at the beginning of treatment or when doses are
changed.
The FDA also advises that people taking antidepressants
be observed for increases in anxiety, panic attacks, agitation, irritability,
insomnia, impulsivity, hostility, and mania. The FDA has not recommended that
people stop using antidepressants but simply to monitor those taking the
medications and, if concerns arise, to contact a doctor.
Beers MH, et al., eds. (2004). Merck Manual of Health and Aging. Whitehouse Station, NJ: Merck Research
Laboratories.
Drugs for cognitive loss and dementia (2007).
Treatment Guidelines From The Medical Letter, 5(54):
9–14.
Verghese J, et al. (2003). Low blood pressure and the
risk of dementia in very old individuals. Neurology,
61(12): 1667–1672.
Garcia A, Zanibbi K (2004). Homocysteine and cognitive
function in elderly people. Canadian Medical Association Journal, 171(8): 897–904.
Shumaker SA, et al. (2003). Estrogen plus progestin
and the incidence of dementia and mild cognitive impairment in postmenopausal
women. The Women's Health Initiative memory study: A randomized controlled
trial. JAMA, 289(20): 2651–2662.
Espeland MA, et al. (2004). Conjugated equine
estrogens and global cognitive function in postmenopausal women: Women's Health
Initiative Memory Study. JAMA, 291(24):
2959–2968.
North American Menopause Society (2004). Abridged
recommendations for estrogen and progestogen use in peri- and postmenopausal
women: October 2004 position statement of the North American Menopause Society.
Menopause Management, 13(6): 12–19. Also available
online: http://www.menopausemgmt.com/issues/13-06/issue.html.
Mathuranath PS, et al. (2000). A brief cognitive test
battery to differentiate Alzheimer's disease and frontotemporal dementia.
Neurology, 55(11): 1613–1620.
Knopman DS, et al. (2001). Practice parameter:
Diagnosis of dementia (an evidence-based review). Neurology, 56(9): 1143–1153.
Wilkinson D, et al. (2003). Donepezil in vascular
dementia. Neurology, 61(4): 479–486.
Malouf R, Birks J (2006). Donepezil for vascular
cognitive impairment. Cochrane Database of Systematic Reviews (4). Oxford: Update Software.
Warner J, et al. (2006). Dementia, search date
February 2006. Online version of Clinical Evidence (15):
1–24.
McShane R, et al. (2006). Memantine for dementia.
Cochrane Database of Systematic Reviews (4). Oxford:
Update Software.
Bird TD, Miller BL (2005). Alzheimer's disease and
other dementias. Harrison's Principles of Internal Medicine, 16th ed., pp. 2393–2406. New York: McGraw-Hill.
U.S. Food and Drug Administration (2005). FDA issues
public health advisory for antipsychotic drugs used for treatment of behavioral
disorders in elderly patients. FDA Talk Paper T05-13.
Available online: http://www.fda.gov/bbs/topics/ANSWERS/2005/ANS01350.html.
Wang PS, et al. (2005). Risk of death in elderly users
of conventional vs. atypical antipsychotic medications. NEJM, 353(22): 2335–2341.
U.S. Department of Health and Human Services (2008).
2008 Physical Activity Guidelines for Americans (ODPHP
Publication No. U0036). Washington, DC: U.S. Government Printing Office.
Available online:
http://www.health.gov/paguidelines/pdf/paguide.pdf.
Roman GC (2002). Vascular dementia revisited:
Diagnosis, pathogenesis, treatment, and prevention. Medical Clinics of North America, 86(3): 477–499.
Verghese J, et al. (2003). Leisure activities and the
risk of dementia in the elderly. New England Journal of Medicine, 348(25): 2508–2516.
Mukamal KJ, et al. (2003). Prospective study of
alcohol consumption and risk of dementia in older adults. JAMA, 289(11): 1405–1413.
Ruitenberg A, et al. (2002). Alcohol consumption and
risk of dementia: The Rotterdam study. Lancet,
359(9303): 281–286.
Jick H, et al. (2000). Statins and the risk of
dementia. Lancet, 356(9242): 1627–1631.
Zandi PP, et al. (2005). Do statins reduce risk of
incident dementia and Alzheimer disease? The Cache County study.
Archives of General Psychiatry, 62(2):
217–224.
Li G, et al. (2004). Statin therapy and risk of
dementia in the elderly. Neurology, 63(9):
1624–1628.
Tzourio C, et al. (2003). Effects of blood pressure
lowering with perindopril and indapamide therapy on dementia and cognitive
decline in patients with cerebrovascular disease. Archives of Internal Medicine, 163(9): 1069–1075.
Richards JB, et al. (2007). Effect of selective
serotonin reuptake inhibitors on the risk of fracture. Archives of Internal Medicine, 167(2): 188–194.
Spector A, et al. (2003). Efficacy of an
evidence-based cognitive stimulation therapy programme for people with
dementia. British Journal of Psychiatry, 183:
248–254.
Graff MJ, et al. (2006). Community-based occupational
therapy for patients with dementia and their caregivers: Randomised controlled
trial. BMJ, 333(1196). Also available online:
http://www.bmj.com/cgi/content/full/333/7580/1196.